Albasanz-Puig, A. Et Al. 2021. Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study). Antimicrobial Agents and Chemotherapy , vol.65, no.8 .

Albasanz-Puig, A., Gudiol, C., Puerta-Alcalde, P., AYAZ CEYLAN, Ç. M., Machado, M., Herrera, F., ... Martín-Dávila, P.(2021). Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study). Antimicrobial Agents and Chemotherapy , vol.65, no.8.

Albasanz-Puig, A. Et Al. "Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)," Antimicrobial Agents and Chemotherapy , vol.65, no.8, 2021

Albasanz-Puig, A. Et Al. "Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)." Antimicrobial Agents and Chemotherapy , vol.65, no.8, 2021

Albasanz-Puig, A. Et Al. (2021) . "Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)." Antimicrobial Agents and Chemotherapy , vol.65, no.8.

@article{article, author={A. Albasanz-Puig Et Al. }, title={Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)}, journal={Antimicrobial Agents and Chemotherapy}, year=2021}